FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311867041> ?p ?o ?g. }

• W4311867041 abstract "Gliomas are the most common malignant primary brain tumors characterized by poor prognosis. The genotyping of tumors using next generation sequencing (NGS) platforms enables the identification of genetic alterations that constitute diagnostic, prognostic and predictive biomarkers. The present study investigated the molecular profile of 32 tumor samples from 32 patients with high-grade gliomas by implementing a broad 80-gene targeted NGS panel while reporting their clinicopathological characteristics and outcomes. Subsequently, 14 of 32 tumor specimens were also genotyped using a 55-gene NGS panel to validate the diagnostic accuracy and clinical utility of the extended panel. The median follow-up was 19.2 months. In total, 129 genetic alterations including 33 structural variants were identified in 38 distinct genes. Among 96 variants (single nucleotide variants and insertions and deletions), 38 were pathogenic and 58 variants of unknown clinical significance. TP53 was the most frequently mutated gene, followed by PTEN and IDH1 genes. Glioma patients with IDH1 mutant tumors were younger and had significantly longer overall survival compared to patients with wild-type IDH1 tumors. Similarly, tumors with TP53 mutations were more likely observed in younger patients with glioma. Subsequently, a comparison of mutational profiles of samples analyzed by both panels was also performed. Implementation of the comprehensive pan-cancer and the MOL panels resulted in the identification of 37 and 15 variants, respectively. Of those, 13 were common. Comprehensive pan-cancer panel identified 24 additional variants, 22 of which were located in regions that were not targeted by the MOL panel. By contrast, the MOL panel identified two additional variants. Overall, the present study demonstrated that using an extended tumor profile assay instead of a glioma-specific tumor profile panel identified additional genetic changes that may be taken into consideration as potential therapeutic targets for glioma diagnosis and molecular classification." @default.
• W4311867041 created "2023-01-01" @default.
• W4311867041 creator A5002833730 @default.
• W4311867041 creator A5005087419 @default.
• W4311867041 creator A5011645616 @default.
• W4311867041 creator A5014605303 @default.
• W4311867041 creator A5018321274 @default.
• W4311867041 creator A5019758131 @default.
• W4311867041 creator A5021513134 @default.
• W4311867041 creator A5031247244 @default.
• W4311867041 creator A5034182778 @default.
• W4311867041 creator A5034507679 @default.
• W4311867041 creator A5041575636 @default.
• W4311867041 creator A5049900739 @default.
• W4311867041 creator A5051365519 @default.
• W4311867041 creator A5063212748 @default.
• W4311867041 creator A5067080871 @default.
• W4311867041 creator A5079965139 @default.
• W4311867041 creator A5081271665 @default.
• W4311867041 creator A5088046602 @default.
• W4311867041 creator A5090741343 @default.
• W4311867041 date "2022-12-08" @default.
• W4311867041 modified "2023-09-30" @default.
• W4311867041 title "Molecular profile and clinical features of patients with gliomas using a broad targeted next generation‑sequencing panel" @default.
• W4311867041 cites W1982088425 @default.
• W4311867041 cites W2000997280 @default.
• W4311867041 cites W2023114647 @default.
• W4311867041 cites W2028196734 @default.
• W4311867041 cites W2028906953 @default.
• W4311867041 cites W2040458067 @default.
• W4311867041 cites W2040827479 @default.
• W4311867041 cites W2044197183 @default.
• W4311867041 cites W2100901335 @default.
• W4311867041 cites W2104958914 @default.
• W4311867041 cites W2108234281 @default.
• W4311867041 cites W2111350087 @default.
• W4311867041 cites W2126817554 @default.
• W4311867041 cites W2148977460 @default.
• W4311867041 cites W2235737683 @default.
• W4311867041 cites W2278061057 @default.
• W4311867041 cites W2366536035 @default.
• W4311867041 cites W2417483443 @default.
• W4311867041 cites W2467961502 @default.
• W4311867041 cites W2566723262 @default.
• W4311867041 cites W2593700942 @default.
• W4311867041 cites W2749025438 @default.
• W4311867041 cites W2770026599 @default.
• W4311867041 cites W2791150552 @default.
• W4311867041 cites W2795979933 @default.
• W4311867041 cites W2805774739 @default.
• W4311867041 cites W2808979164 @default.
• W4311867041 cites W2898789672 @default.
• W4311867041 cites W2933896469 @default.
• W4311867041 cites W2945788231 @default.
• W4311867041 cites W2947352082 @default.
• W4311867041 cites W2951874439 @default.
• W4311867041 cites W2995998912 @default.
• W4311867041 cites W2997849382 @default.
• W4311867041 cites W3028167733 @default.
• W4311867041 cites W3102720020 @default.
• W4311867041 cites W3104623022 @default.
• W4311867041 cites W3176151009 @default.
• W4311867041 cites W3189272102 @default.
• W4311867041 cites W3197275894 @default.
• W4311867041 cites W3203918618 @default.
• W4311867041 cites W4210837388 @default.
• W4311867041 cites W4211132876 @default.
• W4311867041 cites W4220763013 @default.
• W4311867041 cites W4286294404 @default.
• W4311867041 doi "https://doi.org/10.3892/ol.2022.13624" @default.
• W4311867041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36589665" @default.
• W4311867041 hasPublicationYear "2022" @default.
• W4311867041 type Work @default.
• W4311867041 citedByCount "0" @default.
• W4311867041 crossrefType "journal-article" @default.
• W4311867041 hasAuthorship W4311867041A5002833730 @default.
• W4311867041 hasAuthorship W4311867041A5005087419 @default.
• W4311867041 hasAuthorship W4311867041A5011645616 @default.
• W4311867041 hasAuthorship W4311867041A5014605303 @default.
• W4311867041 hasAuthorship W4311867041A5018321274 @default.
• W4311867041 hasAuthorship W4311867041A5019758131 @default.
• W4311867041 hasAuthorship W4311867041A5021513134 @default.
• W4311867041 hasAuthorship W4311867041A5031247244 @default.
• W4311867041 hasAuthorship W4311867041A5034182778 @default.
• W4311867041 hasAuthorship W4311867041A5034507679 @default.
• W4311867041 hasAuthorship W4311867041A5041575636 @default.
• W4311867041 hasAuthorship W4311867041A5049900739 @default.
• W4311867041 hasAuthorship W4311867041A5051365519 @default.
• W4311867041 hasAuthorship W4311867041A5063212748 @default.
• W4311867041 hasAuthorship W4311867041A5067080871 @default.
• W4311867041 hasAuthorship W4311867041A5079965139 @default.
• W4311867041 hasAuthorship W4311867041A5081271665 @default.
• W4311867041 hasAuthorship W4311867041A5088046602 @default.
• W4311867041 hasAuthorship W4311867041A5090741343 @default.
• W4311867041 hasBestOaLocation W43118670411 @default.
• W4311867041 hasConcept C104317684 @default.
• W4311867041 hasConcept C121608353 @default.
• W4311867041 hasConcept C126322002 @default.
• W4311867041 hasConcept C127848430 @default.
• W4311867041 hasConcept C135763542 @default.

• next